Company profile
BioLife Solutions, Inc.
NASDAQ: BLFS · Healthcare · Medical - Instruments & Supplies
#356 of 1,422 Healthcare companies by revenue63rd-percentile growth
EA Score
74BFH 81DQ 77GM 45SS 84
v0.1 · 65/100 weight · provisional
↑ listing tenure, Altman-Z · ↓ 3-yr revenue growth, growth stability
Methodology →Revenue TTM
$99.8M
Rev growth YoY (TTM)
+40.9%
Net income (FY)
-$4.6M
Employees
155
as of 2026-08-10
Market cap
$1.7B
as of 2026-08-10
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$96.2M$96.2M2025
Net income-$4.6M-$4.6M2025
Operating income-$16.6M-$16.6M2025
Total assets$405.9M$405.9M2025
Liabilities$34.0M$34.0M2025
Equity$371.9M$371.9M2025
Revenue trend
FY2019 – FY2025 · USD
FY19
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2024
By product
Product92%
Rental Revenue7%
Service0%
By geography
Not disclosed.
The read
What is BioLife Solutions, Inc.’s revenue?
BioLife Solutions, Inc. booked $96.2M in FY2025 revenue, growing 17% year over year — faster than most Healthcare companies we track, at a -4.8% net margin.
Peers · Healthcare
NeuroPace, Inc.53DMedexus Pharmaceuticals Inc.64CButterfly Network, Inc.62CSIGA Technologies, Inc.73BPulmonx Corporation57CVaso Corporation68BNeighbors
King →Key facts
CEORoderick de Greef
SectorHealthcare
IndustryMedical - Instruments & Supplies
HeadquartersBothell, WA
ExchangeNASDAQ: BLFS
Employees155
IPO date1989-11-22
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.